MADISON, Wisconsin, March 18 /PRNewswire/ --

The Dutch higher education market is one of the world's most advanced in lecture capture and Technical University of Delft leads the pack, recording 80 class hours that attract 10,000 views - each and every week. But the widespread success of this ambitious campus program did not come without the usual challenges.

Sonic Foundry, Inc. (Nasdaq: SOFO), the recognized market leader for rich media webcasting and knowledge management, will host a webinar in which Leon Huijbers will discuss how he and his Multimedia Department overcame the space, funding and workforce shortages that initially threatened the lecture capture initiative.

STOCKHOLM, Sweden, March 18 /PRNewswire/ -- Today marks the European launch of FIRMAGON(R) (degarelix), a new treatment option in hormonal therapy for prostate cancer, with details presented at the 24th Annual European Association of Urology (EAU) Congress in Stockholm. FIRMAGON(R) is a new GnRH receptor blocker indicated for the treatment of patients with advanced hormone-dependent prostate cancer.

STOCKHOLM, Sweden, March 18 /PRNewswire/ --

- Attn: Healthcare Editors

Screening for prostate cancer can reduce deaths by 20%, according to the results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) published online 1700 hours CET 18 March (NEJM, Online First*). ERSPC is the world's largest prostate cancer screening study and provides robust, independently- audited evidence, for the first time, of the effect of screening on prostate cancer mortality.

LONDON, March 18 /PRNewswire/ -- Stafford Hospital is a classic case of the government's 'flawed' privatisation agenda for the NHS, Unite, the largest union in the country, said today (Wednesday, 18 March).

The hospital, run by Mid Staffordshire NHS Foundation Trust, where more than 400 people are said to have died over a three year period - an above average figure - is 'an example of what happens when the target obsessed privatisation culture takes hold'.

David Fleming, Unite National Officer for Health, said: 'This is a classic example of the fragmented and insidious approach to dismantling the NHS and providing alternatives that are never going to be as good.'

SAN DIEGO, March 18 /PRNewswire/ --

Rayspan Corporation, the world's leading innovator of Metamaterial air interface solutions, is proud to announce that its Chief Technology Officer Dr. Maha Achour will give a presentation entitled The Road to 4G through Metamaterial Air Interface Technology: Long Term Evolution (LTE) and Beyond at the third European Conference on Antenna and Propagation (EuCAP 2009). The company will also exhibit its latest WLAN and WWAN Metamaterial handset solutions.

LONDON, March 18 /PRNewswire/ --

Despite the initial regulatory hiccups, the number of biosimilars in the European market is set to increase gradually. The patent expiry of key biopharmaceuticals has opened up numerous lucrative market opportunities, while driving the development of biosimilars. In addition, payers' perception of biosimilars, as viable alternatives to originator drugs due to their safety, efficacy and affordability, will further bolster market prospects.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

HOUSTON, March 18 /PRNewswire/ --

- Novel Stent Platform Designed for Radial Strength, Flexibility

IDEV Technologies Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive technologies, announced today that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for a multi-center clinical trial of its SUPERA stent, a novel stent platform designed for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA). PAD affects more than 8 million people in the U.S. alone and, by the age of 65, 12-20 percent of the population will develop PAD, according to the American Heart Association.

BOZEN, Italy, March 18 /PRNewswire/ -- Health Robotics today announced the European launch of its i.v.STATION Robot with a demonstration at the European Association of Hospital Pharmacists in Barcelona, Spain [Booth 21, Level -1] next week. Health Robotics also announced an updated list of the i.v.STATION installations around the world, and the simultaneous showcase of CytoCare(TM), the world's only Chemotherapy IV Robot, at the EAHP booth of one of its strategic partners (B|Braun, Booths C9-C12).

CALGARY, Canada, March 18 /PRNewswire/ --

- TT-10 Appraisal Well Generates Record Aggregate Rate of 44,240 Barrels per day

Addax Petroleum Corporation (Addax Petroleum or the Corporation) (TSX:AXC and LSE:AXC) today announced flow test results for the TT-10 well, the seventh Cretaceous appraisal and development well drilled on the Taq Taq field by Taq Taq Operating Company, the joint venture company formed by Genel Enerji A.S. (Genel) and Addax Petroleum to carry out the petroleum operations in the Taq Taq license area.

BRUSSELS, March 18 /PRNewswire/ --

In a gala event including the world's foremost leaders in biofuels, PetroAlgae (OTC Bulletin Board: PALG) last night was presented the Sustainable Biofuels Technology Award in the Technology Supplier category at the 2009 World Biofuels Markets in Brussels.